Ligand Pharmaceuticals Inc (LGND)
Sales/Maturities of Investments
$361.72M
Quarterly · Period ending: · USD

LGND Sales/Maturities of Investments
Latest reported$361.72Mperiod ending
Latest reported$361.72Mperiod ending
LGND Quarterly Sales/Maturities of Investments ($5.60M → $361.72M)
Quarterly Sales/Maturities of Investments
High-resolution chart · PNG
LGND sales/maturities of investments history
Quarterly · USD. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | Sales/Maturities of Investments (USD) |
|---|---|
| 361,718,000 | |
| 120,650,000 | |
| 202,180,000 | |
| 53,470,000 | |
| 50,860,000 | |
| 70,774,000 | |
| 45,184,000 | |
| 94,795,000 | |
| 47,056,000 | |
| 75,463,000 | |
| 59,908,000 | |
| 24,761,000 | |
| 56,801,000 | |
| 52,697,000 | |
| 7,009,000 | |
| 24,998,000 | |
| 44,688,000 | |
| 157,696,000 | |
| 31,770,000 | |
| 4,317,000 | |
| 44,341,000 | |
| 140,907,000 | |
| 60,243,000 | |
| 346,615,000 | |
| 0 | |
| 476,436,000 | |
| 611,695,000 | |
| 584,303,000 | |
| 501,742,000 | |
| 332,988,000 | |
| 567,132,000 | |
| 334,717,000 | |
| 56,350,000 | |
| 66,616,000 | |
| 37,357,000 | |
| 24,122,000 | |
| 87,384,000 | |
| 47,771,000 | |
| 6,389,000 | |
| 31,481,000 | |
| 36,929,000 | |
| 68,671,000 | |
| 44,626,000 | |
| 26,269,000 | |
| 1,919,000 | |
| 459,000 | |
| 846,000 | |
| 340,000 | |
| 530,000 | |
| 626,000 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 1,500,000 | |
| 0 | |
| 8,500,000 | |
| 0 | |
| 0 | |
| 5,458,000 | |
| 13,888,000 | |
| 2,734,000 | |
| 10,639,000 | |
| 5,924,000 | |
| 34,743,000 | |
| 2,001,000 | |
| 13,044,000 | |
| 17,316,000 | |
| 15,400,000 | |
| 12,752,000 | |
| -101,000 | |
| 10,352,000 | |
| 9,012,000 | |
| 12,134,000 | |
| -237,000 | |
| 1,091,000 | |
| 7,128,000 | |
| 8,591,000 | |
| 2,778,000 | |
| 6,301,000 | |
| 7,884,000 | |
| 6,575,000 | |
| 15,065,000 | |
| 6,738,000 | |
| 2,945,000 | |
| 22,431,000 | |
| 9,892,000 | |
| 548,000 | |
| 16,797,000 | |
| 760,000 | |
| 4,289,000 | |
| 3,781,000 | |
| 1,223,000 | |
| 3,450,000 | |
| 12,112,000 | |
| 1,901,000 | |
| 591,000 | |
| 6,743,000 | |
| 765,000 |